• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Enforcement Report - Week of October 2, 2024

    FDA

    Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets

    INDIAN PHARMA POST

    Bionpharma`s Generic Doxylamine Succinate, Pyridoxine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week Of June 01, 2022

    FDA

    Enforcement Report - Week of February 9, 2022

    FDA

    Emery Pharma Files FDA Citizen Petition on VitB6 Toxicity & Urges Warning Label

    PRNEWSWIRE

    FDA to Study Perceptions of Instagram Influencers and Their Disclosures

    RAPS

    Class 4 Medicine Defect Information: Xonvea 10 mg/10 mg gastro-resistant tablets

    MHRA

    Enforcement Report - Week of August 14, 2019

    FDA

    Enforcement Report - Week of June 19, 2019

    FDA

    NPPA fixes retail prices of 22 formulations under DPCO, 2013

    PHARMABIZ

    Enforcement Report for Week of February 20, 2019

    FDA

    Enforcement Report - Week of January 9, 2019

    FDA

    Enforcement Report - Week of November 7, 2018

    FDA

    FDA Confirms Paragraph IV Patent Challenge of Bonjesta 209661 (Doxylamine Succinate and Pyridoxine Hydrochloride) Extended-release Tablets

    FDA

    Updated List of New Paragraph IV Patent Certifications - Oct 22

    FDA

    A drug maker paid Kim Kardashian $500,000 for a few social media posts!

    STAT NEWS

    Cipla, Unitaid join hands to reduce HIV drug price

    BIOSPECTRUM

    Duchesnay USA Announces Launch Bonjesta®doxylamine succinate, pyridoxine HCL)

    PR NEWSWIRE

    Report calls into question effectiveness of pyridoxine-doxylamine

    EU PHARMACEUTICAL

    Par Pharm’s Generic Doxylamine Succinate; Pyridoxine HCL Receives Approval In US

    FDA

    Kim Kardashian flouts FDA warning AGAIN to promote `dangerous` sickness pill

    DAILYMAIL

    Laboratoires Colba Inc. Recalls Enerforce Total

    HEALTH CANADA

    Evidence That Prescription Drug For Morning Sickness Works Is Lacking

    FORBES

    Research Data, Missing for Decades, Raise Concerns on Morning Sickness Drug

    STAT

    Actavis Receives FDA Approval for Doxylamine Succinate

    FDA

    Kim Kardashian posts drug’s side effects after FDA warning

    NEW YORK POST

    Duchesnay USA Publishes Corrective Messaging through Kim Kardashian’s Social Media Accounts in Response to FDA’s Request

    DUCHESNAY USA

    Anvisa suspends Dexadoze manufactured by Laboratorio Teuto Brasileiro S / A

    ANVISA

    Advanced Physician Solutions, Inc. initiates Class II recall of Nanpyridoxine due to Lack of Assurance of Sterility

    FDA

    Diclegis® For Morning Sickness Now Available In Puerto Rico

    DUCHESNAY USA

    New technique determines which patients with homocystinuria will respond

    SCIENCE DAILY

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.